j.palacios

TL2 · Breda

Contributes reviews on supplier material. Based in Breda.

Joined 20 August 2025 · last posted 5d

83 posts, newest first. Showing up to 150.

Revisiting: Protein density versus volume when you cannot eat much Replied, post #97 · Nutrition & Training › Protein & intake · 23 Jul 2026 · 13 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once.
Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #2 · Practice › Administration · 18 Jul 2026 · 2 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #29 · Practice › Dosing & titration · 15 Jul 2026 · 24 likes That is a cleaner way of putting what I was circling around.
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #45 · Practice › Interactions · 14 Jul 2026 · 1 like What I can speak to on Antibiotics is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #23 · Compounds › Cagrilintide & amylin analogues · 12 Jul 2026 · 0 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
Coming back to: Telehealth prescribing models in the US Replied, post #11 · Regional › North America · 10 Jul 2026 · 1 like An observation about Telehealth prescribing models that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public…
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #52 · Practice › Administration · 5 Jul 2026 · 29 likes Taking post #49 at face value and following it one step further. Bleeding at the site is common and unremarkable at these needle gauges. Persistent bruising in the same…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #123 · Sourcing › Logistics · 4 Jul 2026 · 29 likes Thank you for the correction. I would rather find out here than later.
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #41 · Sourcing › Independent verification · 25 Jun 2026 · 17 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
Why fasting instructions for oral semaglutide are not optional advice Replied, post #58 · Compounds › Oral incretins · 25 Jun 2026 · 5 likes Understood, and I withdraw the assumption I opened with.
Pooling trials with different estimands Replied, post #43 · Evidence › Meta-analyses · 23 Jun 2026 · 6 likes The confident answers on pooling trials with different estimands and the well-sourced answers are not the same answers, which is the most useful thing I have learned…
Second pass at: Programming during a large energy deficit Replied, post #39 · Nutrition & Training › Resistance training · 22 Jun 2026 · 7 likes I had written a reply contradicting post #36 and deleted it. Here is what survived. Progression during a deficit may mean maintaining rather than adding, and framing…
Conditions that change the calculus rather than forbidding it Replied, post #23 · Safety › Contraindications · 18 Jun 2026 · 11 likes Worth separating two things that post #21 runs together. Conditions is a good example of a question where the honest answer is boring and the interesting answers are…
GLP-1 receptor distribution: central and peripheral Replied, post #69 · Pharmacology › Receptor biology · 14 Jun 2026 · 0 likes Picking up post #66: that is the part I would want checked first. Species differences in receptor pharmacology are substantial in this family, which is one reason…
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #59 · Outcomes › Progress reports · 13 Jun 2026 · 3 likes Thank you for the correction. I would rather find out here than later.
Official shortage notices and what they authorise Replied, post #90 · Access › Shortages · 6 Jun 2026 · 24 likes Planning around a known shortage window is easier than reacting to one, and the notices give advance warning more often than people expect. Posting it because the…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #21 · Analytics › Home & field testing · 14 May 2026 · 17 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
Bioimpedance and hydration: why the number moves Replied, post #43 · Outcomes › Body composition · 11 May 2026 · 29 likes Post #41 put the caveat in the right place and I want to underline it. Photographs under fixed lighting and posture are a genuine record and are the hardest of these to…
Request: show the solution author in the topic list — what changed since Replied, post #53 · Meta › Feature requests · 2 May 2026 · 8 likes Then the honest version is a comparison of the record shapes rather than the scores. How many results, over how long, from which services. That I would use. It is one…
Private prescribing in the UK: what is actually involved Replied, post #5 · Regional › UK & Ireland · 27 Apr 2026 · 20 likes This follows post #2 rather than contradicting it. I have been on both sides of the private prescribing argument in this category within eighteen months, which should…
Reading a home test result without over-claiming Replied, post #18 · Analytics › Home & field testing · 20 Apr 2026 · 1 like A home refractometer is not measuring what people hope it is measuring in these preparations, and the readings are dominated by everything other than the peptide. That…
Sample handling between despatch and injection Replied, post #29 · Analytics › Method validation · 10 Apr 2026 · 17 likes Reading back through the sample handling between despatch threads from last year, the same three questions come up every time and only one of them has ever been…
List price versus negotiated price versus what you pay Started this topic · Access › Pricing · 6 Apr 2026 · 1 like On the subject in the title: List price versus negotiated price versus what you pay Working notes rather than a conclusion. List price versus negotiated price — I have…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #81 · Practice › Interactions · 5 Apr 2026 · 9 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
Reading a home test result without over-claiming Started this topic · Analytics › Home & field testing · 27 Mar 2026 · 1 like Reading a home test result without over-claiming — setting out what I have, and where I think it stops being reliable. Collecting what is known about reading a home…
Preservatives: function, testing, and limits — one year on Replied, post #6 · Pharmacology › Formulation chemistry · 24 Mar 2026 · 15 likes I had written a reply contradicting post #4 and deleted it. Here is what survived. I have no financial interest in anything named in this thread and I want to say so…
Oral versus injected administration claims for BPC-157 Replied, post #25 · Compounds › Repair & healing peptides · 17 Mar 2026 · 9 likes Post #24 describes the usual case. This is about the unusual one. Where I would push back on the oral versus injected administration claims consensus is the confidence,…
[2026 update] Composite endpoints and the component doing the work Replied, post #18 · Evidence › Trials · 3 Mar 2026 · 1 like Adding the measurement that post #15 says would settle it. The confident answers on Composite endpoints and the well-sourced answers are not the same answers, which is…
Preprint servers and what screening they do Replied, post #68 · Evidence › Preprints · 25 Feb 2026 · 28 likes Post #67 is right about the mechanism and I think understates the practical bit. Always label it as a preprint in any discussion. A preprint is not a published trial…
Journal club: LEADER as the historical anchor Replied, post #38 · Evidence › Journal club · 22 Feb 2026 · 0 likes Answering the question post #34 raises rather than the one it answers. Two things can be true about LEADER at once: the mechanism is plausible and the evidence for the…
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #11 · Analytics › HPLC & UHPLC · 22 Feb 2026 · 0 likes I have no financial interest in anything named in this thread and I want to say so before I comment on Area percent versus weight percent, because it is the sort of…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #60 · Analytics › Impurities & related substances · 18 Feb 2026 · 10 likes Scavengers and cleavage-cocktail residues can persist and appear as small early-eluting peaks. They are process-related rather than sequence-related, which is a useful…
Managing an unplanned gap in supply Replied, post #35 · Access › Shortages · 18 Feb 2026 · 11 likes Having read the whole managing an unplanned gap thread before replying: the question in the first post has not actually been answered yet, and three of us have answered…
[2026 update] Composite endpoints and the component doing the work Replied, post #5 · Evidence › Trials · 16 Feb 2026 · 0 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #49 · Clinical › Bloodwork · 11 Feb 2026 · 11 likes Everything in post #46 holds. The case it does not cover is the one I have. Reference intervals would be much easier to settle if anyone reported the denominator.…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #35 · Evidence › Study critique · 8 Feb 2026 · 0 likes Statistical significance and clinical importance are different and both are needed. A significant difference below the minimal important difference is a real finding of…
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #64 · Regional › UK & Ireland · 13 Jan 2026 · 29 likes Building on post #61 rather than restating it. A note on how Private prescribing gets discussed rather than on Private prescribing itself: the confident posts get the…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #46 · Practice › Storage & stability · 5 Jan 2026 · 20 likes This follows post #45 rather than contradicting it. My understanding of Storing lyophilised material long term is a few years old and may have been superseded. If it…
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #10 · Practice › Storage & stability · 4 Jan 2026 · 29 likes Answering the question post #6 raises rather than the one it answers. Two people in this thread mean different things by peptide and are disagreeing about the…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #30 · Pharmacology › Receptor biology · 27 Dec 2025 · 1 like Ghrelin receptor agonism drives growth hormone release in pulses and also increases appetite, which is the effect people most reliably report and least often want. The…
Tracking a preprint to publication: a worked example Replied, post #146 · Evidence › Preprints · 14 Dec 2025 · 16 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #18 · Practice › Side effects · 22 Nov 2025 · 0 likes Dizziness on standing: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #46 · Compounds › Tirzepatide · 12 Nov 2025 · 26 likes This follows post #44 rather than contradicting it. The question underneath tirzepatide titration schedules is usually "how would I tell?" rather than "what is true?",…
Managing an unplanned gap in supply — what changed since Replied, post #112 · Access › Shortages · 10 Nov 2025 · 2 likes A definition problem is doing most of the work in this Managing an unplanned gap discussion. Once the term is pinned down I suspect the disagreement mostly goes away…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #56 · Compounds › Tirzepatide · 21 Oct 2025 · 27 likes Understood, and I withdraw the assumption I opened with.
Where to report an adverse event officially, by region — a second dataset Replied, post #25 · Safety › Adverse events · 16 Oct 2025 · 0 likes The most useful contribution to this subcategory is a completed account: what happened, what was done, and what the outcome was.
Reading an interaction checker output critically Replied, post #18 · Practice › Interactions · 8 Oct 2025 · 18 likes Post #15 is the version of this I will quote in future. One addition. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #103 · Compounds › Cagrilintide & amylin analogues · 5 Oct 2025 · 3 likes Cagrilintide is a long-acting amylin analogue, which puts it in a different mechanistic family from the incretin agonists it is usually discussed alongside. Amylin…
High-resolution MS on aggregates and what it can see Replied, post #64 · Analytics › Mass spectrometry · 10 Sep 2025 · 4 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
A comparison of home results against a laboratory result on the same vial Replied, post #34 · Analytics › Home & field testing · 8 Sep 2025 · 0 likes Understood, and I withdraw the assumption I opened with.
Hypertension improvement and when medication needs revisiting Replied, post #40 · Clinical › Comorbidities · 4 Sep 2025 · 26 likes Adding a null result on hypertension improvement. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #33 · Evidence › Journal club · 31 Aug 2025 · 1 like What I want from this indirect comparison thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #56 · Compounds › Retatrutide · 20 Aug 2025 · 5 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
System suitability injections: if they failed, the run did not happen Replied, post #24 · Analytics › HPLC & UHPLC · 19 Aug 2025 · 11 likes The most useful reply I ever got about system suitability injections was a request to state my units. It sounds like pedantry and it has saved me twice.
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #33 · Analytics › COA interpretation · 14 Aug 2025 · 2 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #19 · Evidence › Journal club · 14 Aug 2025 · 16 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
A ten-fold dose error caught before injection — one year on Replied, post #128 · Devices › Syringes & needles · 4 Aug 2025 · 19 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #20 · Compounds › Tirzepatide · 29 Jul 2025 · 0 likes Worth separating GIP component of tirzepatide as a question about the compound from GIP component of tirzepatide as a question about the documentation. They get…
Canadian access and provincial variation — one year on Replied, post #30 · Regional › North America · 25 Jul 2025 · 3 likes The public assessment documents published at approval are free, detailed and largely unread here. That is all the detail I have. Someone else will have more.
A field-by-field walk through a certificate of analysis Replied, post #77 · Analytics › COA interpretation · 16 Jul 2025 · 26 likes A definition problem is doing most of the work in this field-by-field walk through a certificate discussion. Once the term is pinned down I suspect the disagreement…
Payment mechanics and the recovery options that do not exist — what changed since Replied, post #16 · Sourcing › Payments · 22 Jun 2025 · 17 likes Payment mechanics is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #14 · Sourcing › Vendor reports · 19 Jun 2025 · 20 likes Building on post #12 rather than restating it. Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #46 · Clinical › Comorbidities · 22 May 2025 · 0 likes The version of hepatic steatosis that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and…
Follow-up: What other technical communities get right that we do not Replied, post #102 · Lounge › Off topic · 18 May 2025 · 16 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #31 · Practice › Reconstitution · 1 Apr 2025 · 3 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
Transit times by route, from a logged dataset — the long version Replied, post #75 · Sourcing › Logistics · 27 Mar 2025 · 0 likes Post #71 put the caveat in the right place and I want to underline it. The version of Transit times that circulates here is a simplification of a simplification. It is…
Reading a chromatogram someone posted without axes Replied, post #14 · Analytics › HPLC & UHPLC · 24 Mar 2025 · 11 likes Retention time is only comparable within a laboratory on a given method. Quoting a retention time across two reports as evidence of identity is not a valid comparison.
Journal club: SURMOUNT-1, read without the press release Replied, post #80 · Evidence › Journal club · 19 Mar 2025 · 0 likes On SURMOUNT-1: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here…
Charge states for a 4 kDa peptide, worked through Replied, post #144 · Analytics › Mass spectrometry · 18 Mar 2025 · 25 likes Noted, and thank you for writing it out rather than summarising it.
Anxiety in the first weeks: drug, situation, or both Replied, post #62 · Wellbeing › Mental health · 15 Mar 2025 · 0 likes Reading back through the anxiety threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That seems…
Consistent declarations and why they matter more than clever ones Replied, post #101 · Sourcing › Logistics · 28 Feb 2025 · 0 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Coming back to: Official shortage notices and what they authorise Replied, post #33 · Access › Shortages · 22 Feb 2025 · 9 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum…
SNAC and the mechanism of oral peptide absorption Replied, post #2 · Compounds › Oral incretins · 14 Feb 2025 · 1 like Anyone comparing published oral and injectable efficacy should check whether the comparison is within one trial or across two. Across two, the populations differ and…
Coming back to: Renal impairment: what the labelling says about dose Replied, post #34 · Clinical › Special populations · 3 Feb 2025 · 17 likes The most useful contribution here is usually a citation to whichever published document comes closest, with a plain statement of how far it is from the question.
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #100 · Evidence › Journal club · 21 Jan 2025 · 1 like Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
[2026 update] Step therapy requirements and how to satisfy them Replied, post #116 · Access › Insurance & coverage · 11 Jan 2025 · 33 likes Picking up post #114: that is the part I would want checked first. I would keep Step therapy requirements and the decision it usually gets used for separate in this…
What changed in 2026, by region Replied, post #21 · Access › International · 14 Dec 2024 · 0 likes Adding the measurement that post #18 says would settle it. Both are useful and they are different contributions. A first-hand account and a citation answer different…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #61 · Clinical › Comorbidities · 19 Oct 2024 · 29 likes Reading back through the Hypertension improvement threads from last year, the same three questions come up every time and only one of them has ever been answered…
About the Protein & intake category Replied, post #9 · Nutrition & Training › Protein & intake · 23 Sep 2024 · 0 likes Where somebody reports losing strength, intake and training stimulus are the first two things to look at rather than the compound.
Coming back to: Preparing for an appointment: one page, three questions Replied, post #54 · Clinical › Prescriber conversations · 10 Sep 2024 · 13 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. I have written this out at…
Correlation in a self-tracked dataset: what it can support Replied, post #137 · Research Methods › Statistics · 25 Aug 2024 · 2 likes Where I have landed on correlation, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has…
Chronic kidney disease and the FLOW result Replied, post #20 · Clinical › Comorbidities · 16 Aug 2024 · 0 likes Picking up post #17: that is the part I would want checked first. The honest answer on chronic kidney disease is that it depends, and the useful part is the list of…
Journal club: FLOW and the renal composite, component by component Replied, post #28 · Evidence › Journal club · 11 Jul 2024 · 28 likes Post #26 describes the usual case. This is about the unusual one. Where the group cannot agree, record the disagreement rather than resolving it by seniority. The…